Avenzo Therapeutics Announces FDA Clearance of Investigational New Drug Application for AVZO-103, a Potential Best-in-Class Nectin4/TROP2 Bispecific Antibody-Drug Conjugate
AVZO(AVZO) SAN DIEGO--(BUSINESS WIRE)--Avenzo Therapeutics Announces FDA Clearance of IND Application for AVZO-103, a Potential Best-in-Class Nectin4/TROP2 Bispecific ADC
September 2, 2025Clinical Trials
Read more →